An Unusual Case of Massive Prosthetic Aortic Valve Thrombosis in a Hypocoagulated Patient

Hamidi M *

Department of Cardiology, IBN SINA Hospital, Mohammed V University, Rabat, Morocco.

El Bahri L

Department of Cardiology, IBN SINA Hospital, Mohammed V University, Rabat, Morocco.

Rami H

Department of Cardiology, IBN SINA Hospital, Mohammed V University, Rabat, Morocco.

Fellat N

Department of Cardiology, IBN SINA Hospital, Mohammed V University, Rabat, Morocco.

Fellat R

Department of Cardiology, IBN SINA Hospital, Mohammed V University, Rabat, Morocco.

*Author to whom correspondence should be addressed.


Abstract

Background: Prosthetic valve thrombosis (PVT) is a rare but life-threatening complication of mechanical valve replacement, with an estimated incidence of 0.5–6% per patient-year, depending on valve position and anticoagulation adequacy (Dangas et al., 2016). While thrombus formation is the primary mechanism, pannus (fibrotic tissue ingrowth) coexists in up to 30% of obstructive PVT cases, complicating diagnosis and management (Deviri et al., 1991; Ha et al., 2018). Clinical presentation ranges from incidental findings to fulminant cardiogenic shock, with mortality exceeding 50% in obstructive left-sided PVT without prompt intervention (Cáceres-Lóriga et al., 2006). Diagnosis relies on multimodal imaging, primarily transthoracic echocardiography (TTE) and cinefluoroscopy. Current guidelines prioritize emergency surgery for hemodynamically unstable patients, while fibrinolysis is reserved for high-surgical-risk cases or resource-limited settings (Otto et al., 2021).

Case Presentation: A 34-year-old woman with a history of rheumatic heart disease (diagnosed at age 12) and subsequent mechanical aortic (19-mm St. Jude) and mitral (27-mm St. Jude) valve replacement at age 28 presented with acute pulmonary edema and cardiogenic shock. She reported a 2-week history of progressive dyspnea, hemoptysis, and macroscopic hematuria. Postoperative anticoagulation with Acenocoumarol (4 mg/day) was initiated for thromboembolism prophylaxis. However, the patient demonstrated poor adherence over the past year, and despite self-reported adherence in the preceding month, her admission INR was paradoxically elevated to 6.5.

Physical examination revealed hypotension (85/46 mmHg), tachycardia (112 bpm), bilateral rales, and new murmurs of aortic stenosis and regurgitation. Transthoracic echocardiography (TTE) demonstrated severe prosthetic aortic valve obstruction (mean gradient: 98 mmHg; effective orifice area: 0.3 cm²) with concomitant severe regurgitation. Cinefluoroscopy confirmed prosthetic valve thrombosis (PVT), showing leaflets immobilized in a semi-open position (opening angle <10°). Emergency redo aortic valve replacement revealed mixed fresh thrombus and circumferential pannus obstructing the prosthesis; the mitral valve remained patent.

Conclusion: This case highlights the paradox of life-threatening prosthetic valve thrombosis despite supratherapeutic anticoagulation, underscoring the roles of pannus formation and turbulent flow in small-valve prostheses. It reinforces that PVT requires urgent multimodal imaging and emergent intervention, even in anticoagulated patients, and emphasizes stricter adherence monitoring.

Keywords: Aortic prosthesis, valve obstruction, thrombus, pannus, anticoagulation


How to Cite

M, Hamidi, El Bahri L, Rami H, Fellat N, and Fellat R. 2025. “An Unusual Case of Massive Prosthetic Aortic Valve Thrombosis in a Hypocoagulated Patient”. Asian Journal of Cardiology Research 8 (1):355-62. https://doi.org/10.9734/ajcr/2025/v8i1286.

Downloads

Download data is not yet available.